Forest Infasurf
Executive Summary
Marketing of the lung surfactant calfactant will begin in October, following Buffalo federal court ruling that Infasurf does not infringe Abbott's Survanta (beractant) patent. The ruling overturns a lower court decision against Forest in September. Infasurf was approved in July 1998 for respiratory distress syndrome (1"The Pink Sheet" July 13, p. 4)